Overall, these findings indicate that an SMO-independent, GLI2-dependent HH signaling activation may be implicated in meningeal infiltration in T-ALL patients who display persistently low levels of GLI1 expression. The gene discussed is GLI1; the disease is acute lymphoblastic leukemia.